Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Cipla acquires 4 nutrition products from Wanbury for Rs 89 crore

      Cipla acquires 4 nutrition products from Wanbury for Rs 89 crore

      Farhat Nasim10 Feb 2020 11:58 AM IST
      New Delhi: Homegrown pharma firm Cipla on Saturday announced the acquisition of nutrition products portfolio from Wanbury Ltd. The company has...
      Bevetex Vs Bevatas: Delhi HC junks Sun Pharma arm plea against Intas Pharma over trademark

      Bevetex Vs Bevatas: Delhi HC junks Sun Pharma arm plea against Intas Pharma over trademark

      Farhat Nasim9 Feb 2020 11:30 AM IST
      New Delhi: In a major setback to drug giant Sun Pharmaceuticals Ltd.'s arm, Sun Pharma Laboratories Ltd., the Delhi high court has recently dismissed...
      FDI in drugs and pharma sector rose to Rs 2065 crore in April-Sept FY20: Government

      FDI in drugs and pharma sector rose to Rs 2065 crore in April-Sept FY20: Government

      Farhat Nasim9 Feb 2020 11:00 AM IST
      The foreign direct investment (FDI) equity inflow in the drugs and pharmaceutical sector stood at Rs 1,842 crore in FY 2018-19, Minister of State...
      Dr Reddys launches generic version of Syprine in US

      Dr Reddys launches generic version of Syprine in US

      Farhat Nasim9 Feb 2020 10:45 AM IST
      In a regulatory filing, Dr Reddy's Laboratories announced the launch of Trientine Hydrochloride capsules USP, 250 mg, a therapeutically equivalent...
      Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

      Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

      Farhat Nasim9 Feb 2020 10:30 AM IST
      "The company has entered into the definitive agreements (share subscription and share purchase agreement and shareholders agreement)...with Kedaara...
      Capping Trade Margins of pharma would save Rs 984 crore, Ashwini Kumar Choubey informs LS

      Capping Trade Margins of pharma would save Rs 984 crore, Ashwini Kumar Choubey informs LS

      Farhat Nasim7 Feb 2020 4:53 PM IST
      There would be an annual saving of approx. Rs. 984 crores to the patients under 'Trade margin Rationalisation Approach' by the National Pharmaceutical...
      Sun Pharma reports Rs 6923.40 crore total expenses in Q3

      Sun Pharma reports Rs 6923.40 crore total expenses in Q3

      Farhat Nasim7 Feb 2020 4:43 PM IST
      New Delhi: Drug major Sun Pharmaceutical Industries on Thursday reported a 26.43 per cent decline in its consolidated net profit to Rs 913.52 crore...
      Strides Pharma arm inks pact with Pharmaceutics International to acquire 18 ANDA

      Strides Pharma arm inks pact with Pharmaceutics International to acquire 18 ANDA

      Farhat Nasim7 Feb 2020 3:34 PM IST
      "Strides...announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, Singapore, has entered into a definitive asset...
      Overcharging on Anti-diabetic, Cardiac Care Drugs: Rs 245.96 crore recovered from Pharma Firms, Minister informs Parliament

      Overcharging on Anti-diabetic, Cardiac Care Drugs: Rs 245.96 crore recovered from Pharma Firms, Minister informs Parliament

      Farhat Nasim6 Feb 2020 4:43 PM IST
      NPPA has detected and issued about 162 demand notices against the pharmaceutical companies for overcharging consumers on the sale of Anti-diabetic and...
      Cadila Healthcare Ahmedabad facility clears USFDA inspection

      Cadila Healthcare Ahmedabad facility clears USFDA inspection

      Farhat Nasim5 Feb 2020 9:15 AM IST
      United States Food and Drug Administration (USFDA) inspected the manufacturing facility of Alidac Pharmaceuticals, the company's wholly-owned...
      NPPA pulls Gilead on price exemption plea for its Hepatitis B drug

      NPPA pulls Gilead on price exemption plea for its Hepatitis B drug

      Farhat Nasim4 Feb 2020 3:12 PM IST
      New Delhi: The apex drug price regulator, National Pharmaceuticals Pricing Authority (NPPA) has recently sought clarifications from the US-drugmaker...
      Zydus Cadila gets DGCI nod for diabetes drug Saroglitazar Magnesium

      Zydus Cadila gets DGCI nod for diabetes drug Saroglitazar Magnesium

      Farhat Nasim4 Feb 2020 10:30 AM IST
      "Zydus Cadila has received the approval from the Drug Controller General of India (DCGI) for use of Saroglitazar Mg in the treatment of type II...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok